http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107753489-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04 |
| filingDate | 2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107753489-B |
| titleOfInvention | Beriberi treating preparation and its preparation method |
| abstract | The invention discloses a beriberi preparation, wherein miconazole nitrate and triclosan are main sterilization components, and the miconazole nitrate and the triclosan can generate a synergistic effect by matching use to enhance the sterilization effect; the urotropine mainly plays a role in astringing and arresting sweating in the formula, and has a bactericidal effect; dexamethasone is a corticoid drug and mainly plays a role in diminishing inflammation and relieving itching in the formula; dimethyl sulfoxide mainly plays a role in assisting dissolution in the formula, so that miconazole nitrate and dexamethasone are dissolved, and the dimethyl sulfoxide has a transdermal effect, enhances the transdermal absorption of the medicament and enhances the medicament effect; laurocapram is a transdermal absorbent, so that the transdermal absorption function of the medicine is enhanced; the glycerin is a humectant and mainly plays a role in moistening skin, reducing irritation and increasing drug attachment in the formula; the medical ethanol is mainly used as a solvent and has the sterilization effect; the menthol and the essence are used as a flavoring agent to improve the smell of the medicine and improve the use experience; it also has foot odor masking effect. |
| priorityDate | 2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.